The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 684.40
Bid: 684.20
Ask: 685.00
Change: -5.00 (-0.73%)
Spread: 0.80 (0.117%)
Open: 689.40
High: 691.40
Low: 678.60
Prev. Close: 689.40
ENT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Invesco Ltd.: Form 8.3 - Entain PLC

14 Jan 2021 13:35

Invesco Ltd.: Form 8.3 - Entain PLC

PUBLIC DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Invesco Ltd.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree  Entain PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure  13-01-2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”  Yes: MGM Resorts International

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:  0.01 Ordinary IM00B5VQMV65
 InterestsShort positions
 Number %Number %
(1) Relevant securities owned and/or controlled: 12,046,528 2.05%   
(2) Cash-settled derivatives:        
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:       
TOTAL: 12,046,528 2.05%   

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(73) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1©, copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale  Number of securities Price per unit
Ordinary Sale 2,925 13.92 GBP

 (b) Cash-settled derivative transactions

Class of relevant security Product descriptione.g. CFD Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
         

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Typee.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii) Exercise

Class of relevant security Product descriptione.g. call option Exercising/ exercised against Number of securities Exercise price per unit
        

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealinge.g. subscription, conversion Details Price per unit (if applicable)
       

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO

Date of disclosure: 14-01-2021
Contact name: Philippa Holmes
Telephone number: +441491 417447

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
22nd Sep 202111:12 amBUSForm 8.3 - Entain plc
22nd Sep 20219:59 amPRNForm 8.3 - Entain Plc
22nd Sep 20217:00 amRNSStatement re Possible Offer
21st Sep 20213:29 pmRNSStatement re Possible Offer
17th Sep 20219:04 amRNSBlock Listing Application
1st Sep 202110:13 amRNSTotal Voting Rights
17th Aug 202112:39 pmRNSBoard Committee Membership Change
12th Aug 20211:31 pmRNSTAM expected to grow 3x and extension into esports
12th Aug 20217:00 amRNSInterim Results
2nd Aug 20213:43 pmRNSTotal Voting Rights
23rd Jul 20214:10 pmRNSHolding(s) in Company
16th Jul 20215:55 pmRNSPricing and allocation of new Term Loan
8th Jul 20217:10 amRNSEntain Increases Investment in Exclusive Content
8th Jul 20217:00 amRNSH1 Post Close Trading Update
7th Jul 20214:50 pmRNSBanking Facility and Refinancing Update
5th Jul 202110:47 amRNSStatement regarding Tabcorp Holdings Limited
1st Jul 20211:58 pmRNSTotal Voting Rights
30th Jun 20219:40 amRNSModern Slavery Act Transparency Statement 2021
25th Jun 202111:19 amRNSResult of AGM
14th Jun 202110:58 amRNSTR1: Notification of major holdings
10th Jun 20217:30 amRNSEntain Set for Three Million Fans to Bet on Euros
1st Jun 20214:00 pmRNSBlock Listing Six Monthly Return
1st Jun 202110:13 amRNSTotal Voting Rights
27th May 20215:10 pmRNSNotice of AGM
19th May 20217:00 amRNSEntain Publishes ESG Report
18th May 20218:53 amRNSRetirement from a directorship held by a director
4th May 20219:15 amRNSTotal Voting Rights
27th Apr 20217:00 amRNSTabcorp update
21st Apr 20212:00 pmRNSBetMGM business update
16th Apr 202110:07 amRNSBetMGM Investor Day details
15th Apr 20217:30 amRNSEntain launches employee share ownership plan
15th Apr 20217:00 amRNSQ1 trading update
9th Apr 20217:05 amRNSDirector Declaration
7th Apr 20217:00 amRNSResult of extended acceptance period for Enlabs AB
1st Apr 20211:29 pmRNSTotal Voting Rights
1st Apr 20217:26 amRNSEntain expands global regulated markets by 30%
29th Mar 20217:00 amRNS2020 Annual Report
26th Mar 202110:56 amRNSEntain Secures ISO Environmental and H&S Standards
25th Mar 20211:25 pmRNSDirector/PDMR Shareholding
22nd Mar 20217:00 amPRNEntain completes offer to Enlabs shareholders
17th Mar 20217:00 amRNSBoard appointment
9th Mar 20217:00 amPRNRegulatory Approval for Enlabs offer
4th Mar 20217:01 amRNSEntain commits to being carbon net zero by 2035
4th Mar 20217:00 amRNSFinal Results
3rd Mar 20217:04 amPRNSupplement to Offer document re. Enlabs AB
1st Mar 20212:00 pmRNSBetMGM business update
1st Mar 202111:14 amRNSTotal Voting Rights
1st Mar 20217:00 amPRNUpdate re. Offer for Enlabs AB
26th Feb 20218:24 amRNSHolding(s) in Company
24th Feb 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.